| Trial registration number
|
NCT04771559 |
Full text link
Last imported at : Feb. 27, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04771559
|
First author
Last imported at : Aug. 4, 2021, 2 p.m.
Source : ClinicalTrials.gov
|
AYSE IREM YASIN, MD
|
Contact
Last imported at : Aug. 4, 2021, 2 p.m.
Source : ClinicalTrials.gov
|
ayseiremyasin@gmail.com
|
Registration date
Last imported at : Feb. 27, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2021-02-25
|
Recruitment status
Last imported at : Aug. 4, 2021, 2 p.m.
Source : ClinicalTrials.gov
|
Completed
|
Study design
Last imported at : Feb. 27, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
nonRCT
|
Allocation
Last imported at : Feb. 27, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Non-randomized
|
Design
Last imported at : Feb. 27, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Feb. 27, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Open label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
multi-center
|
Study aim
Last imported at : Feb. 27, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Prevention
|
Inclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
for the patient group :
patients with pathological and clinical cancer diagnosis
older than 18 years
patients two doses of covid-19 vaccine administered
volunteering to participate in the study
for the control group :
no known cancer diagnosis or history
older than 18 years
two doses of covid-19 vaccine administered
volunteering to participate in the study -
|
Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
not volunteering to participate in the study
< 18 years
not administered two doses of the covid-19 vaccine
covid-19 infection history -
|
Number of arms
Last imported at : Feb. 27, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : Feb. 27, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Bezmialem Vakif University
|
Inclusion age min
Last imported at : Feb. 27, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : Feb. 27, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : Feb. 27, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Turkey
|
Type of patients
Last imported at : Feb. 27, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Healthy volunteers
|
Severity scale
Last imported at : Feb. 27, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
N/A
|
Total sample size
Last imported at : Aug. 4, 2021, 2 p.m.
Source : ClinicalTrials.gov
|
1500
|
primary outcome
Last imported at : Feb. 27, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Antibody levels
|
Notes
Last imported at : Feb. 27, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : Feb. 27, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "2;500 cancer patients", "treatment_id": 1923, "treatment_name": "Inactivated sars-cov-2 vaccine (vero cell)", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "2;500 healthy volunteers as control", "treatment_id": 1923, "treatment_name": "Inactivated sars-cov-2 vaccine (vero cell)", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}]
|